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Abstract
Hepcidin is an innate immune element which decreases the iron absorption from diet and 
iron releasing from macrophage cell. In contrast to the chemical iron chelators, there has been 
limited effort applied to the specific use of hepcidin as a new drug for decreasing the iron 
overload.
Hepcidin is produced in different biological systems. For instance, E-coli is used for human 
hepcidin expression, however, post-translational modification is impaired. We have used a 
simple baculovirus expression system (BES) to improve the hepcidin folding and activity. 
Hepcidin Messenger Ribonucleic acid (mRNA) was isolated from mouse liver cells and its 
complementary Deoxyribonucleic acid (cDNA) was produced and amplified. PFastBac HTB 
vector was used for recombinant bacmid production. Recombinant baculovirus was produced 
using SF-9 cell line. The mouse hepcidin-1 protein was expressed in a large quantity and 
functional tests were performed for this recombinant peptide. The yield of hepcidin in BES was 
20 µg/mL and anti-histidine (anti-His) tag antibody was used for the confirmation of hepcidin 
on western blot nitrocellulose paper. Functional tests showed that mouse hepcidin accumulates 
iron in the macrophage cell line J774A.1 up to 63%. In addition, our data showed that the 
mouse hepcidin-1 has less toxicity compared to the synthetic human hepcidin-25 (p = 0.000). 
Keywords: Hepcidin; Baculovirus expression system; Functional study; J774A.1.
Introduction
Hepcidin was originally isolated from the 
human serum and urine (1, 2). Hepcidin is 
predominantly found in liver cell and weekly 
express in stomach, intestine, colon, heart, 
thymus and alveolar macrophages cells (3, 
4). Sequential analysis of protein has shown 
that hepcidin is a cysteine rich peptide with 
several disulphide bonds (5). It is conserved 
among species from fishes to mammals (2). 
Humans have only one copy of the hepcidin 
gene, however, mice have two copies named 
hepcidin-1 and hepcidin-2 (3). Mouse hepcidin 
gene consists of 3 exons and 2 introns which is 
located on chromosome-7 (3). Reports show that 
mouse hepcidin-1 (but not hepcidin-2) involve 
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in iron regulation, iron storage and hemoglobin 
level (6, 7). Hepcidin causes internalization and 
degradation of iron exporter ferroportin, which 
is present on the cell surface of macrophage 
and enterocyte cells. Thus, hepcidin inhibits the 
release of iron by macrophages and iron uptake 
by enterocytes (8).
Antimicrobial activity against several 
microorganisms were also pointed in hepcidin 
derived from different species (9, 10). Moreover, 
hepcidin as an iron inhibitor represents an 
important class of anti-tumor agents since iron is 
an essential trace element that is vital for DNA 
synthesis (11).
Iron overload is the dangerous side 
effect of blood transfusion that occurs in 
hemoglobinopathies, such as thalassemia (12, 
13). Deferiprone and deferoxamine are routinely 
used for removal excess iron (14). In contrast 
to the chemical iron chelators, there has been 
limited effort applied to the specific use of 
hepcidin for decreasing iron overload in serum.
In spite of the reports describing the effect of 
hepcidin on iron regulation in the literature, there 
is little information about mouse hepcidin-1 
effect on iron accumulation and also cell 
viability on macrophage cells, as important cells 
that participate in iron metabolism. 
Hepcidin can be extracted through purification 
from plasma and urine, but the yield of purified 
crude hepcidin in this way is low (2). The 
second way is synthesis of hepcidin. Preparation 
pathway of functional synthetic hepcidin is very 
difficult and refolding procedures are required 
(15). Alternatively, hepcidin can be produced 
in bacterial expression system. The advantage 
of this expression system is its low cost and 
high productivity, but its post-translational 
modifications can be impaired in comparison 
with the expression in mammalian cells (16).
We tried to use a simple biological expression 
system that might have more similarity to 
mammalian cells. Therefore, we hypothesis 
that the baculovirus expression system (BES) 
would be efficient for this purpose (17, 18). The 
other advantage of this system is the lack of 
contamination with bacterial component such as 
LPS and hence, applying this protein would not 
activate immune responses (19).
We decided to use BES for cloning and 
expression of mouse hepcidin-1 peptide. In this 
study, isolation and cloning of the mouse mRNA 
encoding hepcidin protein was carried out and 
its production in baculovirus expression system 
was considered. For functional assessment, 
we compared mouse hepcidin-1 and synthetic 
human hepcidin-25 effect on iron concentration 
and cell viability in J774A.1 cells line. To the 
best of our knowledge, the present study is the 
first work that considers all the above aspects for 
expression and functional assessment of mouse 
hepcidin-1 in the baculovirus expression system.
Experimental
Cloning and production of recombinant 
baculovirus
The liver of sacrificed male C57/Bl6 mice 
was isolated and its total mRNA was extracted 
from liver cells using RNeasy Mini Kit (Qiagen, 
Germany). Then, the hepcidin cDNA was 
amplified utilizing Qiagen one-step RT-PCR Kit. 
The primer sequences were as follows: forward 
primer (BamHI), 5-GGATCCATGGCACTCAG 
CACTCGGAC-3 and reverse primer (XbaI), 
5-TCTAGAGGCTCT A GGCTATGTTTTGC-3. 
Patterns of digestion with ALU I enzyme was 
used for the preliminary assessment of PCR 
product.
The purified PCR product was ligated into 
the “PTZ57R/T” vector. One of the obtained 
recombinant plasmids, was then sequenced 
(Macrogen, Korea). Subsequently, this plasmid 
was digested with BamHI and XbaI restriction 
enzymes and then the insertion was subcloned 
into the “PFastBac HTB” plasmid (Invitrogen, 
USA). The insertion caused the addition of a hexa 
histidine sequence into the 5´ end of the hepcidin 
cDNA. The fidelity of the insertion in PFastBac 
B vector was confirmed by PCR analysis 
using polyhedrin primer and reverse primer of 
hepcidin cDNA and digestion with NcoI enzyme. 
Four selected recombinant plasmids were then 
sequenced (Macrogen, Korea) to verify the 
orientation and proper framing of insertion.
The selected recombinant vector was used 
for the production of recombinant bacmid. 
Afterward, the bacmids were isolated utilizing 
midiprep kit (Invitrogen, USA) from the selected 
colonies.
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Insect SF9 cell line (Invitrogen, USA) 
was used for the production of recombinant 
baculovirus. Before the transfection, cells were 
grown (27°C) using “SF-900 II SFM” cell culture 
medium (Invitrogen, USA) supplemented with 
1x penicillin/streptomycin/neomycin(Gibco 
BRL, USA) in order to adopt them to this 
growth condition. According to manufacturer’s 
instruction, the transfection of these cells 
occurred using cellfectin reagent. After the 
cells showed signs of late stage of infection, 
the medium containing the baculovirus was 
collected and the amount of it was calculated.
Expression and analysis of mouse hepcidin-1
For hepcidin expression, multiplicity of 
infections (MOIs) 5, 10 and 20 were utilized in 
monolayer SF-9 cell (20). Infected SF-9 cells 
were harvested 48, 72 and 96 h post-infection 
for hepcidin expression analysis. Expression of 
the recombinant mouse hepcidin-1 in the SF-9 
cell was examined by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blot analysis. Samples were 
electrophoresed in 15% SDS PAGE gels. After 
the electrophoresis, the proteins were transferred 
to a nitrocellulose membrane (Sartorius AG-
USA) at 400 mA for 45 min using an electroblot 
system (Bio-Rad, USA). Membranes were then 
washed extensively with PBS buffer (0.15M, pH 
7.4) and blocked with 3% of skim milk (Sigma, 
USA). The membranes were shacked for 1.5 h 
at room temperature with anti His-tag antibody 
(Calbiochem, USA) at final concentration 
of 4 µg/mL in PBS buffer, containing 2% 
bovine serum albumin (BSA) (Sigma, USA). 
After stringent washing using PBS-Tween-
BSA solution (0.05% Tween, 2% BSA), the 
membranes were incubated with 1 : 1000 HRP 
conjugated sheep anti mouse (Sigma, USA) for 
1.5 h. After washing the membranes, hepcidin 
was detected using DAB as the substrate for 
HRP and appearance of brown colored protein 
bands on the membrane (Sigma, USA).
The hepcidin effect on iron concentration
The His-tag bounded at recombinant mouse 
hepcidin-1 was cleaved with enterokinase 
enzyme according to manufacturer’s instruction 
(Promega, USA). Human hepcidin refolded 
using refolded buffer (20 mM Tris, pH 7.4, 
150 mM NaCl, 100 mM KCl, 5 mM GSH and 
0.5 mM GSSG) at final concentration of 100 
µg/mL (incubated 24 h in 4°C). J774A.1 cell 
line (Pasteur Institute, Iran), was utilized for 
evaluating the hepcidin effect on iron export. 
The cells were cultured in DMEM medium 
(Sigma, USA) supplemented with 1x penicillin, 
streptomycin, neomycin (Invitrogen, USA) and 
10% fetal bovine serum (Sigma, USA).
The cells were seeded into a 6-well plate with 
1 × 106 cells/well in 2 mL DMEM medium and 
incubated for 24 h simultaneously with 4 or 8 µg 
of hepcidin. In another groups, synthetic human 
hepcidin-25 (PRIMM, Italy) and BSA (dissolved 
in refolding buffer) were used with the same 
concentration. After incubation, cells were washed 
three times with PBS (0.15 M, pH = 7.5) and then 
lysed in 2% SDS. Eventually, total proteins were 
precipitate with 20% trichloroacetic acid and free 
iron was measured in supernatant using atomic 
absorption tool (Perkin Elmer, 2380, USA).
The hepcidin effect on cell viability
Cell viability for hepcidin was examined 
using the MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 
5 diphenyl tetrazolium) proliferation assay (21).
The J774A.1 cell line was seeded into a 24-
well plate at a density of 4 × 104 cells/well in 
1 mL DMEM medium. Recombinant mouse 
hepcidin-1 was added to the wells with the 
concentrations of 2, 3, 4, 5, 6, 7 and 8 μg/well. 
Synthetic human hepcidin-25 and BSA were 
also used with the same concentration in the 
other groups. Then, plates were incubated for 
24 h at 37°C. Briefly, MTT was added to wells 
at the final concentration of 0.5 mg/mL and the 
plates were incubated for 4 h at 37°C. Thereafter, 
medium was removed and the cells were lysed 
in DMSO. Subsequently the conversion of MTT 
to formazan, corresponding to cell viability, was 
assessed by ELISA reader at 540 nm.
Results and Discussion
Expression of mouse hepcidin-1
Hepcidin cDNA was amplified using specific 
primers (mentioned in materials and methods). 
After the gel electrophoresis, the amplified 
cDNA was appeared as a clear band at 260 
Yazdani Y et al. / IJPR (2011), 10 (3): 559-568
562
bp (Figure 1). Comparing the cDNA pattern 
with the patterns present at NCBI information, 
confirmed that the amplified segment would be 
hepcidin cDNA. The Lane 2 in Figure 1 indicate 
a digested pattern of amplified cDNA after 
the treatment with ALU-I restriction enzyme. 
Nucleotide sequential determination of hepcidin 
cDNA indicated that the sequence pattern had 
only one restriction site for the ALU-I enzyme at 
the position of 112. As a result of digestion, one 
segment with 112 bp and one with 157 bp were 
displayed in the pattern of gel electrophoresis.
The cDNA was inserted into “PFastBac 
HTB” and recombinant vector was produced. 
The DNASIS software (Hitachi software 
engineering, Japan) was applied to look for the 
pattern of restriction sites on the recombinant 
vector. Then, the NcoI enzyme was selected for 
the determination of the inserting orientation in 
the cloning site. After the analysis, it was found 
that the recombinant vector had one “restriction 
site” before “cloning site” on “PFastBac HTB 
plasmid” and one “restriction site” on forward 
primer. Figure 2 shows the orientation of hepcidin 
cDNA in cloning site of “PFastBac HTB vector”. 
The lanes 2 and 3 indicate that the target gene 
is in wrong orientation. The colonies that have 
wrong orientation were discarded from this step. 
Those colonies with correct orientation were 
used for sequencing. Afterward, recombinant 
bacmid was produced when DH10 cells were 
transformed by recombinant “PFastBac HTB” 
vector (Figure 3).
M13 forward and reverse primers were 
utilized for the evaluation of recombinant 
bacmid. The Pattern of gel electrophoresis 
illustrates the occurrence of proper homologous 
recombination between recombinant vector and 
bacmid genome (Figure 3: Lanes 2, 5 and 6). 
Subsequently, SF-9 cells were transfected with 
the recombinant bacmid and the baculoviruses 
were successfully produced as a result of this 
transfection. Ninety-nine h post-transfection 
of the cells, the baculoviruses were collected 
from the lysed cells. After the baculoviruses got 
amplified in the SF-9 cells in sufficient amount, 
the MOIs 5, 10 and 20 were used for protein 
expression assessment.
The gene expression of hepcidin in SF-9 cells 
is illustrated in Figure 4. After 24 h, hepcidin 
expression in MOIs 5, 10 and 20 resulted in the 
bands observed in lanes 2, 3 and 4. Moreover, 
lane 1 shows the expression pattern of all the 
genes in SF-9 cells which were transfected 
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Figure 1. PCR product of hepcidin cDNA in 1% agarose gel 
electrophoresis. Lane M is the molecular marker (GeneRuler™ 
50 bp DNA Ladder). Lane 1 is the effect of ALU-1 restriction 
enzyme on PCR product confirming it as a hepcidin cDNA. 
Lane 2 is PCR product with 260 bp weight expected for 
hepcidin cDNA.
Figure 2. Patterns of “PFastBac HTB” digestion with NcoI 
enzyme on the obtained recombinant plasmids.
Lane M is the molecular marker (GeneRuler™ 50 bp DNA 
Ladder). Lanes 1, 4, 5, 6 and 7, show correct orientation of 
hepcidin cDNA in the cloning site of recombinant bacmid. 
Lanes 2 and 3 show a band with approximately 260 bp, 
confirming the wrong orientation of hepcidin cDNA in the 
cloning site of “PFastBac HTB” vector.
1000
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concentrations for positive and negative control 
groups, respectively.
Intra-cellular iron concentration was 
determined using atomic absorption device 24 
h post-incubation. Results of iron concentration 
are summarized in Table 1. The obtained data 
showed that in concentration of 4 µg, the 
effect of the mouse recombinant hepcidin-1 
was lower than the synthetic hepcidin-25 on 
iron concentration (p = 0.016). However, the 
effect of both types of hepcidin (Table 1) on 
iron accumulation in the cells was significantly 
higher than BSA as the control group (p = 
0.000).
Toxicity assay
Both types of hepcidin with the concentration 
of 2-8 µg/mL as well as BSA were added 
separately to the tissue culture wells containing 
4 × 104 J774A.1 cells. The viability of the cells 
was evaluated by MTT assay. The results are 
without using recombinant bacmid (negative 
control). Hepcidin gene expression bands are 
shown in lanes 2, 3 and 4 with approximately 
10 KDa. However, the lane 1 does not contain 
the hepcidin band. Hepcidin protein purification 
was performed by using nickel column and the 
resulting band is seen in lane 5. The lanes 2 and 3 
in Figure 5 show a pattern of all the genes which 
were expressed in the SF-9 cells transfected with 
MOI.20. Expression of hepcidin gene is seen in 
a band of approximately 10 KDa. Our results 
reveal that the optimum time for the protein 
expression is 72 h post-infection. Hepcidin 
expression products were confirmed by western 
blotting using anti-his tag antibody (Figure 6).
Comparison of mouse and human hepcidin 
function
Functional assessment was performed by 
purification of hepcidin on nickel column. An 
amount of 1 × 106 J774A.1 cells were cultured 
in 12-well plates containing 2 mL of DMEM 
medium. Then, the cells were incubated with 
4 and 8 μg of purified mouse hepcidin-1. 
Synthetic human hepcidin-25 and bovine serum 
albumin (BSA) were added with the same 
10000
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Figure 3. Agarose gel electrophoresis of the recombinant 
bacmid. Lane M is the molecular marker (GeneRuler™ DNA 
Ladder Mix). Lanes 1, 3, 4 and 7 show the 300 bp bands which 
confirm that the homologous recombination for bacmids has 
not occurred. Lanes 2, 5 and 6 illustrate the 2680 bp amplified 
bands, confirming the correct homologous recombination.
Figure 4. Protein pattern of cells transfected with mouse 
hepcidin-1 electrophoresed in 15% SDS-Polyacrylamide Gel.
Lane M is the molecular marker (Pageruler™ Prestained Protein 
Ladder). The lane 1 is the pattern of total protein products 
isolated from SF-9 cells transfected with natural baculovirus 
(without hepcidin gene) as negative control. Lanes 2, 3 and 4 
are protein products after 24 h from SF-9 cells transfected with 
recombinant bacmid with MOI.5, 10 and 20 respectively. As it 
is seen, more expressions are obtained with more MOI. Lane 
5 illustrates a pure 10 KDa band of mouse hepcidin-1 after 
passing the total protein products through nickel columns for 
the purification process.
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summarized in Table 2. The analysis indicates 
that the viability of the cells with the mouse 
hepcidin is much higher than synthetic hepcidin 
with the p- value of 0.000-0.007 for all the 
concentrations used. In addition, the effect of 
BSA in cell viability was more similar to the 
effect of mouse hepcidin-1 than that of human 
hepcidin-25. In other words, the toxicity of 
mouse hepcidin is much less than the human 
synthetic hepcidin-25.
Discussion
Hepcidin was purified as a novel peptide 
from the human blood and was called LEAP-
1(1). Park et al. (2001) described the same 
peptide from the liver and due to its origin was 
named hepcidin (2). Hepcidin is involved in 
regulation of iron hemostasis (22) and play a 
role in host defence against microbial invasion 
(23). In addition, hepcidin gene has been cloned 
from fish (24, 25), canine (26) and human (2). 
Escherichia coli (27, 28) and Pichia pastori 
were used for their expression (29). Hepcidin 
characteristics and function are search for the 
basic science development (30-32) and disease 
mechanism involvement in clinic (33, 34). In the 
present study, the effect of mouse hepcidin-1 as a 
new drug was investigated on iron concentration 
and cell viability in J774A.1 as macrophage cell 
line. By designing the specific primers, hepcidin 
cDNA was amplified from mouse liver mRNA. 
Consequently, DNA fragment of 260 bp was 
produced. Previous reports in three independent 
researches indicated that the mouse hepcidin-1 
has 251 nucleotides (3, 35, 36). We added two 
six bp nucleotide on forward and reveres primers 
for directional cloning of hepcidin cDNA to 
the vector. The hepcidin sequence reported by 
Strausberg (2002) was utilized for the restriction 
map analysis by DNASIS software. This 
analysis showed that the target sequence had 
only one restriction site in the position of 112 for 
“ALU- I” restriction enzyme. This restriction site 
has been confirmed by Nicolas (35) and Pigeon 
(3) previously. According to the manufacturer’s 
Figure 5. Mouse hepcidin-1 expression in SF-9 cells and the 
electrophoresis of the proteins in 15% SDS-Polyacrylamide 
Gel.The lane M is the molecular marker (Pageruler™ 
Prestained Protein Ladder). The lane 1 is the pattern of total 
protein products isolated from SF-9 cells transfected with 
natural baculovirus (without hepcidin gene).
The lane 2 is the total of proteins isolated from supernatant 
of SF-9 cells transfected with recombinant bacmid (with the 
hepcidin gene) with MOI.20 in 72 h post-incubation time 
period. Mouse hepcidine-1 protein is approximately 10 KDa. 
The lane 3 has the same conditions as lane 2 except with the 96 
h post-incubation time period.
Figure 6. Western blot of the mouse hepcidin-1.
The lane M is the molecular marker (Pageruler™ Prestained 
Protein Ladder). The lane 1 is Anti-His tag antibody binding 
to 10 KDa protein produced in SF-9 cell transfected with 
recombinant baculovirus and specifies mouse hepcidin-1. The 
lane 2 is the negative control. This lane was loaded with total 
proteins extracted from the SF-9 cells transfected with natural 
baculovirus (without hepcidin gene).
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instruction, M13 forward and reverse primers are 
utilized for the assessment recombinant bacmids 
and a segment with 2430 bp plus the size of 
insertion segment (251 bp) was seen in positive 
colonies. Amplified segment in our project 
indicates that the homologous recombination 
had occurred (Figure 2: Lanes 2, 5 and 6).
In the present investigation, “BamHI” 
restriction enzyme has cross-reacting with 
“XbaI”. However, previous reports indicate 
that these enzymes have specific effect on their 
recognition sites (37). Our experiment shows 
that two out of seven colonies (35%) (Figure 
2) had cross-reacting effect. In other words, the 
sticky end produced by “BamHI”, was bounded 
to the sticky end produced by “XbaI”.
The largest amount of hepcidin was produced 
in MOI.10 after 24 h post-infection. However, 
when cells were incubated for 96 h, no significant 
difference was observed between the MOI.5 and 
most of the MOIs. In the baculovirus expression 
system reported by Kim et al. (2007), the highest 
protein expression was in MOI.5. On the other 
hand, Posse     et al. (2008) used MOI.5 for 
optimum conditions, as well (38, 39). The details 
of our results can be clarified as follows:
The existent baculovirus in MOI.5, used 
all capacity of insect cell line for the protein 
expression, therefore, most of MOIs had no 
effect on this process (40).
The produced hepcidin is a foreign protein in 
SF-9 cell line. Synthesis of any foreign protein 
consumes cell sources such as amino acids and 
may decrease the protein expression in host cell 
Concentration 4 µg 8 µg
Mouse hepcidin-I 44 ± 1.0 54 ± 1.52
Human hepcidin-25 47 ± 1.52 56 ± 2.0
p- value 0.016 0.44
BSA 29 ± 0.57 33 ± 1.0
p- value
H M H M
0.000 0.000 0.000 0.000
Table 1. The effect of hepcidin on iron accumulation in 
J774A.1 cell line.
The data show the mean ± SD of atomic absorption tool for 
iron accumulation (ng/106 cells) in the J774A.1 cells. The 
comparison of means was performed with one-way ANOVA 
test and the significant level was        p ≤ 0.05. The BSA effect 
was compared with both human (H) and mouse (M) hepcidin 
independently.
when its concentration increases (41).
Ruan et al. (2008) have reported that 
maximum yield of exogenous protein in SF-9 
cell was achieved after 72 h post-infection by 
recombinant baculovirus (42). Our results show 
that 72 h would be the optimum condition for 
production of intact and functional hepcidin. 
In addition, infection time period was tested 
for more than 72 h (i.e. 96 h) and the hepcidin 
expression was not different from 72 h. On the 
western blot analysis, anti-His tag antibody was 
used for the indirect confirmation of hepcidin 
expression. Our result revealed that this antibody 
has not direct correlation with the relative 
amount of hepcidin expression. For this finding, 
one possibility is considerable.  His-tag epitope 
is hidden inside the protein, thus, its epitope 
is not properly in access with the anti-His tag 
antibody (43).
Researchers have reported that the yield 
of protein expression was 5-15 µg/mL in 
baculovirus expression system (44), 55-60 µg/
mL in bacterial expression system (45) and 
100 µg/mL in fungal expression system (29). 
The yield of our hepcidin product was 20 µg/
mL and this is more appropriate for baculovirus 
expression system.
According to the reports, if hepcidin binds 
to ferroportin channel, the channel will become 
degrade and will inhibit the iron export from 
the cells (46). Chaston et al. indicate that 
ferroportin levels decreased in hepcidin treated 
macrophages (47). In addition, reports show that 
human hepcidin-25 decreases the iron uptake by 
50% in Caco-2 cells (intestinal cell line) (48). 
Our results reveal that iron accumulates up to 
63% in J774A.1 cells once treated with mouse 
hepcidin-1. Human hepcidin in comparison with 
the mouse hepcidin-1 had more effect with 4 
µg dosage on intra-cellular iron concentration 
(p = 0.016). This achievement can be explained 
through two possibilities. The first possibility 
is that the human hepcidin-25 might have 
more effect on the iron metabolism (15). 
The other possibility which can explain this 
achievement, is the fact that recombinant mouse 
hepcidin might lose some of its activity during 
the purification and post-purification process 
(imidazole removement and His-tag cleavage) 
(49). However, with the dosage of 8 µg, the 
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difference between the two types of hepcidin 
was not statistically significant (p = 0.44). These 
could also be explained by two possibilities. 
First, this cell line may express distinct levels of 
ferroportin channel, so the increase in hepcidin 
dosage treatment have no significant effect on 
intra-cellular iron concentration (50). Second, 
cell culture medium has limited the source of iron 
and the cells have restriction for the iron uptake. 
Thus, due to the limitation of iron, increasing 
hepcidin would not effect on iron concentration 
in the cells.
Physiological and biochemical effects 
of hepcidin in biological systems are under 
investigation. Jyh-Yih chen et al. stated that fish 
hepcidin TH2-3 product have cytotoxic effect 
on HT1080 cell line (51). Our data show that 
synthetic human hepcidin-25 in comparison with 
mouse hepcidin-1 or BSA has a higher cytotoxic 
effect.
In conclusion, during this study, we produced 
functional mouse hepcidin-1 as a new drug at 
a high concentration and it was revealed that 
mouse hepcidin-1 has considerable effect on iron 
accumulation in macrophage cells and thus, it 
can decrease iron overload in serum and prevent 
iron precipitat
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